Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Allo-HSCT on Bone Remodeling: Evolution of Bone Mineral Density and Architecture Measured by Bone Densitometry Coupled With FRAX / TBS in Allo-HSCT

NCT05161026 is registered in ClinicalTrials.gov with University Hospital, Caen as lead sponsor.

NCT NCT05161026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05161026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Allo-HSCT on Bone Remodeling: Evolution of Bone Mineral Density and Architecture Measured by Bone Densitometry Coupled With FRAX / TBS in Allo-HSCT
Lead sponsor
University Hospital, Caen
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 10, 2021
Completion date
December 1, 2027
Enrollment
120 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

myeloid leukemia, acute